Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.8%

1 terminated/withdrawn out of 57 trials

Success Rate

96.4%

+9.9% vs industry average

Late-Stage Pipeline

16%

9 trials in Phase 3/4

Results Transparency

0%

0 of 27 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A
26(60.5%)
Phase 2
6(14.0%)
Phase 4
5(11.6%)
Phase 3
4(9.3%)
Phase 1
1(2.3%)
Early Phase 1
1(2.3%)
43Total
N/A(26)
Phase 2(6)
Phase 4(5)
Phase 3(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (57)

Showing 20 of 57 trials
NCT07395752Not ApplicableRecruiting

Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study

Role: collaborator

NCT06410755Not ApplicableActive Not Recruiting

Home-based Rehabilitation Monitoring System With Wearable Devices and Self-Report Application

Role: collaborator

NCT06837324Not ApplicableRecruiting

Effect of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder

Role: collaborator

NCT07529574Not ApplicableNot Yet Recruiting

Efficacy and Safety of a Theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression

Role: collaborator

NCT07515859Completed

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Role: collaborator

NCT07413120Phase 3Completed

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

Role: collaborator

NCT06637943Not Yet Recruiting

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

Role: collaborator

NCT05933005Not ApplicableCompleted

Intervention Utilizing a Computerized Cognitive Rehabilitation Program (D-kit/EF1)

Role: collaborator

NCT05621772Not ApplicableCompleted

Meridian Activation Remedy System for Parkinson's Disease

Role: lead

NCT06977594Not ApplicableNot Yet Recruiting

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Role: collaborator

NCT06969768Completed

Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model

Role: collaborator

NCT03449082Phase 2Completed

Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)

Role: collaborator

NCT05922176Recruiting

Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis

Role: collaborator

NCT06461923Not ApplicableRecruiting

Home-based Gait Rehabilitation Service Using the Insole-type Gait Analysis Device for Children With Cerebral Palsy

Role: collaborator

NCT04582760Not ApplicableCompleted

Early Mobilization in Ventilated SEpsis & Acute Respiratory Failure Study

Role: collaborator

NCT05806346Not ApplicableRecruiting

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Role: collaborator

NCT04147065Phase 4Recruiting

Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study)

Role: collaborator

NCT05957822Phase 4Recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Role: collaborator

NCT06394596Completed

Predicting Prognostic Factors in Kidney Transplantation Using A Machine Learning

Role: collaborator

NCT06233708Completed

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant

Role: collaborator